Researchers assessed the efficacy of trimethoprim-sulfamethoxazole in reducing risk of severe infections among patients with antineutrophil cytoplasm antibody-associated vasculitis.
Researchers assessed the efficacy of trimethoprim-sulfamethoxazole in reducing risk of severe infections among patients with antineutrophil cytoplasm antibody-associated vasculitis.
Leonard Calabrese, DO, discussed the risks and complications of SARS-CoV-2 among immunocompromised patients at the Interdisciplinary Autoimmune Summit virtual session.
Leonard Calabrese, DO, discussed the risks and complications of SARS-CoV-2 among immunocompromised patients at the Interdisciplinary Autoimmune Summit virtual session.